European Archives - Page 1083 of 1136 - European Medical Journal

Holmium Laser Enucleation of the Prostate (HoLEP) in Ambulatory Surgery

The focus of this work is the need to give an update on the holmium laser enucleation of the prostate (HoLEP) technique in ambulatory surgery.

Evolving Techniques for Surgical Treatment of Benign Prostatic Hyperplasia

The management of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) is one of the most topical areas in urology. Although most…

EMJ Urology 3.2 2015

Hello and welcome to the second edition of European Medical Journal Urology, our publication devoted to covering recent developments in all of the…

EMJ

The Scottish Medicines Consortium Approves Gilead’s Zydelig® q (Idelalisib) for the Treatment of Follicular Lymphoma That Is Refractory to Two Prior Lines of Treatment in Adult Patients

Foster City, CA, 11 May 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Scottish Medicines Consortium (SMC) has approved Zydelig…

EMJ

Medac GmbH supports Guideline on Intravesical Instillations of BCG/MMC

Hamburg / Wedel (11 May 2015). medac GmbH has provided the European Association of Urology Nurses (EAUN) with an unrestricted educational grant to…

EMJ

Domestic Violence and the Negotiation for Contraception

WOMEN experiencing domestic violence often have their freedom and choices taken away from them, not least their reproductive health choices.

EMJ

Long Distance Running: A Sign of Desirable Genes

REPRODUCTIVE potential could be higher in those proficient at long distance running, research suggests. Pre-birth levels of testosterone have…

EMJ

One in Five People Will Develop Heart Failure

One person in five is expected to develop heart failure in developed countries, a disease with no cure but which is largely preventable.

EMJ

Subclinical Hypothyroidism and its Impact on Reproductive Health

Subclinical hypothyroidism (SCH) is defined by elevated thyroid-stimulating hormone (TSH) levels in the presence of normal thyroxine (T4) levels.

Re: State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer – Forward to the past – Again

Castration-resistant prostate cancer (CRPC) management is enjoying a renaissance following the marginal but significant beneficial impact of recent novel…